CALGARY, Alberta -- Skymark Research, a leading provider of small- and micro-cap independent investment research, today initiated coverage on Lodgian Inc. . Skymark Research is currently offering a complimentary trial subscription.
We are introducing a new service called Merger Arbitrage Mondays to highlight merger arbitrage opportunities that exist in acquisitions that are yet to be completed. If you are not familiar with merger or risk arbitrage, you can read about it in a section of the March 2009 investment newsletter titled Merger Arbitrage and the Pfizer-Wyeth Deal (PFE). That deal delivered gains of 27.34% including dividends over a 7.5 month period. On an annualized ...
Stock News 
